feed,title,long_url,short_url
SeekingAlpha,Goldman Sachs cut to Neutral at BofA as capital markets seen easing,https://seekingalpha.com/news/3785740,
SeekingAlpha,Regenxbio on go with mid-stage RGX-202 trial for Duchenne muscular dystrophy,https://seekingalpha.com/news/3785739,
